Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone

References

• RothovaASuttorp-van SchultenMSFrits TreffersWKijlstraACauses and frequency of blindness in patients with intraocular inflammatory diseaseBr J Ophthalmol1996803323368703885
   PubMed Web of Science ®Google Scholar
• NussenblattRBThe natural history of uveitisInt Ophthalmol1990145–63033082249907
   PubMed Web of Science ®Google Scholar
• Thomkins-NetzerOTalatIBarALong-term clinical outcome and causes of visual loss in patients with uveitisOphthalmology20141212387239225178807
   PubMed Web of Science ®Google Scholar
• de SmetMDTaylorSRBodaghiBUnderstanding uveitis: the impact of research on visual outcomesProg Retin Eye Res20113045247021807112
   PubMed Web of Science ®Google Scholar
• JabsDANussenblattRBRosenbaumJTStandardization of uveitis nomenclature for reporting clinical data. Results of the First International WorkshopAm J Ophthalmol200514050951616196117
   PubMed Web of Science ®Google Scholar
• KempenJHSugarEAJaffeGJFluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edemaOphthalmology20131201852185923706700
   PubMed Web of Science ®Google Scholar
• FreemanGMatosKPavesioCECystoid macular oedema in uveitis: an unsolved problemEye (Lond)200115121711318279
   PubMed Web of Science ®Google Scholar
• JapACheeSPImmunosuppressive therapy for ocular diseasesCurr Opin Ophthalmol200819653554018854699
   PubMed Web of Science ®Google Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol200714481281718036872
   PubMed Web of Science ®Google Scholar
• FardetDLKassarACabaneJFlahaultACorticosteroid-induced adverse events in adultsDrug Saf20073086188117867724
   PubMed Web of Science ®Google Scholar
• ArmalyMFStatistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of responseInvest Ophthalmol1965418719714283012
   PubMedGoogle Scholar
• ArmalyMFEffect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eyeArch Ophthalmol19637049249914078871
   PubMedGoogle Scholar
• BakriSJBeerPMThe effect of intravitreal triamcinolone acetonide on intraocular pressureOphthalmic Surg Lasers Imaging20033438639014509462
   PubMed Web of Science ®Google Scholar
• KogureAOhkoshiKKogureSYamaguchiTKishiSEfficacy and retention times of intravitreal triamcinolone acetonide for macular edemaJpn J Ophthalmol20085212212618626735
   PubMed Web of Science ®Google Scholar
• KonstantopoulosAWilliamsCPNewsomRSLuffAJOcular morbidity associated with intravitreal triamcinolone acetonideEye20072131732016710433
   PubMed Web of Science ®Google Scholar
• NguyenQDCallanDDugelPGodfreyDGGoldsteinDAWilenskyJTTreating chronic non-infectious posterior segment uveitis: the impact of cumulative damage. Proceedings of an expert panel roundtable discussionRetina200626Suppl 81616395131
   PubMed Web of Science ®Google Scholar
• KarimRSykakisELightmanSFraser-BellSInterventions for the treatment of uveitic macular edema: a systematic review and meta-analysisClin Ophthalmol201371109114423807831
   PubMedGoogle Scholar
• HallerJABandelloFBelfortRJrOZURDEX GENEVA Study GroupRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology201011761134114620417567
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRJrOZURDEX GENEVA Study GroupDexamethasone intravitreal implant in patients with macular edema related to branch or central vein occlusion: twelve-month study resultsOphthalmology2011118122453246021764136
   PubMed Web of Science ®Google Scholar
• KuppermannBDBlumenkranzMSHallerJADexamethasone DDS Phase II Study GroupRandomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edemaArch Ophthalmol2007125330931717353400
   PubMed Web of Science ®Google Scholar
• HunterRSLoboAMDexamethasone intravitreal implant for the treatment of noninfectious uveitisClin Ophthalmol201151613162122140307
   PubMedGoogle Scholar
• LowderCBelfortRLightmanSDexamethasone intravitreal implant for noninfectious intermediate or posterior uveitisArch Ophthalmol201112954555321220619
   PubMed Web of Science ®Google Scholar
• HallerJADugelPWeinbergDVChouCWhitcupSMEvaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edemaRetina200929465118827732
   PubMed Web of Science ®Google Scholar
• Chang-LinJEAttarMAcheampongAAPharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implantInvest Ophthalmol Vis Sci2011521808620702826
   PubMed Web of Science ®Google Scholar
• Tomkins-NetzerOTaylorSRJBarATreatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitisOphthalmology20141211649165424650556
   PubMed Web of Science ®Google Scholar
• Zarranz-VenturaJCarrenoEJohnstonRLMulticenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequencyAm J Ophthalmol20141581136114525217856
   PubMed Web of Science ®Google Scholar
• Nobre-CardosoJChampionEDarugarAFelALehoangPBodaghiBTreatment of non-infectious uveitic macular edema with the intravitreal dexamethasone implantOcul Immunol Inflamm Epub2016322
   Web of Science ®Google Scholar
• CaoJHMulvalhillMZhangLJoondephBCDaceyMFDexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammationOphthalmology20141211649165424650556
   PubMed Web of Science ®Google Scholar
• ArcinueCACerònOMFosterCSA comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitisJ Ocul Pharmacol Ther20132950150723297752
   PubMed Web of Science ®Google Scholar
• Multicenter Uveitis Steroid Treatment Research GroupThe multicenter uveitis steroid treatment (MUST) trial: rationale, design and baseline characteristicsAm J Ophthalmol2010149455055620097325
   PubMed Web of Science ®Google Scholar
• AdeniranJMFJusufbegovicDSchaalSCommon and rare ocular side-effects of the dexamethasone implantOcul Immunol Imflamm Epub201675
   Google Scholar
• KishoreSASchaalSManagement of anterior chamber dislocation of dexamethasone implantOcul Immunol Inflamm2013211909123323589
   PubMed Web of Science ®Google Scholar
• Pardo-LópezDFrancés-MuñozEGallego-PinazoRDíaz-LlopisMAnterior chamber migration of dexamethasone intravitreal implant (Ozurdex®)Graefes Arch Clin Exp Ophthalmol2012250111703170421861084
   PubMed Web of Science ®Google Scholar
• Marín-LambíesCGallego-PinazoRGarcía-DelpechSDíaz-LlopisMOzurdex® y afaquia: una combinaciòn a evitar [Ozurdex(®) and aphakia: a combination to avoid]Arch Soc Esp Oftalmol2012876191192 Spanish22633612
   PubMedGoogle Scholar
• BurkholderBMMoradiAThorneJEDunnJPThe dexamethasone intravitreal implant for noninfectious uveitis: practice patterns among uveitis specialistsOcul Immunol Inflamm201523644445326517764
   PubMed Web of Science ®Google Scholar
• Di AntonioLTotoLCarpinetoPMastropasquaADe NicolaCMastropasquaLMacular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusionEur J Ophthalmol201424113413723709332
   PubMed Web of Science ®Google Scholar
• De BenedettoUBattaglia ParodiMKnutssonKALattanzioRBandelloFIaconoPMacular hole after injection of intravitreal implant for macular oedema due to central retinal vein occlusionActa Ophthalmol2013911e75e7722863290
   PubMed Web of Science ®Google Scholar